Cargando…

Severe COVID‐19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis

BACKGROUND: A major clinical feature of severe coronavirus diease 2019 (COVID‐19) is microvascular thrombosis linked to endothelial cell activation. Consistent with this, a number of studies have shown that patients with severe COVID‐19 have highly elevated plasma levels of von Willebrand Factor (VW...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mobayen, Golzar, Dhutia, Amrita, Clarke, Candice, Prendecki, Maria, McAdoo, Stephen, Keniyopoullos, Renos, Malik, Talat, Laffan, Michael, Willicombe, Michelle, McKinnon, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435526/ https://www.ncbi.nlm.nih.gov/pubmed/34532629 http://dx.doi.org/10.1002/rth2.12582

Ejemplares similares

SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19
por: Prendecki, Maria, et al.
Publicado: (2020)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay
por: Riddell, Anne, et al.
Publicado: (2018)

Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
por: Clarke, Candice L., et al.
Publicado: (2021)

Anti–glomerular basement membrane disease during the COVID-19 pandemic
por: Prendecki, Maria, et al.
Publicado: (2020)

Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients
por: Spensley, Katrina J., et al.
Publicado: (2022)

Von Willebrand Factor, Angiodysplasia and Angiogenesis
por: Randi, Anna M., et al.
Publicado: (2013)

Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
por: Prendecki, Maria, et al.
Publicado: (2020)

In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor
por: Badirou, Idinath, et al.
Publicado: (2012)

The Cost of Von Willebrand Disease in Europe: The CVESS Study
por: Morgan, George, et al.
Publicado: (2022)

Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era
por: Clarke, Candice, et al.
Publicado: (2020)

Primary IgA nephropathy: current challenges and future prospects
por: Penfold, Rose S, et al.
Publicado: (2018)

Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization
por: Tempest-Roe, Shenzhen, et al.
Publicado: (2022)

Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
por: Prendecki, Maria, et al.
Publicado: (2021)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study
por: Martin, Paul, et al.
Publicado: (2022)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
por: Gisby, Jack S., et al.
Publicado: (2022)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
por: Kalot, Mohamad A., et al.
Publicado: (2021)

Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor
Publicado: (1986)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2021)

Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease
por: Turner-Stokes, Tabitha, et al.
Publicado: (2021)

Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

Von Willebrand Disease: An Overview
por: Bharati, K. Pavani, et al.
Publicado: (2011)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients
por: Thomson, Tina, et al.
Publicado: (2022)

Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
por: Ward, Soracha E., et al.
Publicado: (2021)

Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
por: Gleeson, Sarah, et al.
Publicado: (2023)

Treatment of patients with von Willebrand disease
por: Tuohy, Emma, et al.
Publicado: (2011)

The Molecular Genetics of von Willebrand Disease
por: Berber, Ergül
Publicado: (2012)

Regulation of plasma von Willebrand factor
por: Desch, Karl C
Publicado: (2018)

Von Willebrand's Disease: Pathogenesis and Management
por: Dormandy, Katharine M.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_igr6csma4ed8g126l861ai7427